Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Department of Otolaryngology – Head & Neck Surgery, |
RCV001375400 | SCV001571881 | uncertain significance | Hearing impairment | 2021-04-12 | criteria provided, single submitter | clinical testing | PM2_Moderate, PM3_Supporting, PP3_Supporting |
Fulgent Genetics, |
RCV002488191 | SCV002781494 | uncertain significance | Autosomal dominant nonsyndromic hearing loss 4B; Hearing loss, autosomal recessive 113 | 2021-09-23 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005094505 | SCV005814889 | uncertain significance | not provided | 2024-10-24 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 379 of the CEACAM16 protein (p.Arg379Trp). This variant is present in population databases (rs771692758, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with CEACAM16-related conditions. ClinVar contains an entry for this variant (Variation ID: 1065067). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |